California Public Employees Retirement System’s Puma Biotechnology PBYI Stock Holding History

California Public Employees Retirement System’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-62,300	Closed	-$606K	–	2533
2021 Q1	$606K	Sell	62,300 -5,386	-8%	-$60.1K	﹤0.01%	2841
2020 Q4	$694K	Sell	67,686 -1,300	-2%	-$13.2K	﹤0.01%	2717
2020 Q3	$696K	Buy	68,986 +1,800	+3%	+$18.3K	﹤0.01%	2534
2020 Q2	$701K	Sell	67,186 -1,856	-3%	-$19.2K	﹤0.01%	2465
2020 Q1	$583K	Buy	69,042 +3,342	+5%	+$32.5K	﹤0.01%	2333
2019 Q4	$575K	Hold	65,700	–	–	﹤0.01%	2665
2019 Q3	$707K	Buy	65,700 +8,600	+15%	+$92.9K	﹤0.01%	2437
2019 Q2	$726K	Sell	57,100 -500	-0.9%	-$11.5K	﹤0.01%	2342
2019 Q1	$2.23M	Sell	57,600 -1,600	-3%	-$48.9K	﹤0.01%	1702
2018 Q4	$1.21M	Sell	59,200 -5,700	-9%	-$171K	﹤0.01%	2078
2018 Q3	$2.98M	Sell	64,900 -5,400	-8%	-$260K	﹤0.01%	1643
2018 Q2	$4.16M	Sell	70,300 -35,000	-33%	-$2.03M	0.01%	1418
2018 Q1	$7.17M	Sell	105,300 -8,233	-7%	-$616K	0.01%	1097
2017 Q4	$11.2M	Buy	113,533 +5,533	+5%	+$619K	0.02%	851
2017 Q3	$12.9M	Buy	108,000 +800	+0.7%	+$74.4K	0.02%	727
2017 Q2	$9.37M	Buy	107,200 +2,300	+2%	+$129K	0.02%	871
2017 Q1	$3.9M	Sell	104,900 -4,600	-4%	-$168K	0.01%	1453
2016 Q4	$3.36M	Buy	109,500 +70,000	+177%	+$3.03M	0.01%	1567
2016 Q3	$2.65M	Sell	39,500 -2,900	-7%	-$147K	﹤0.01%	1738
2016 Q2	$1.26M	Sell	42,400 -1,400	-3%	-$43.8K	﹤0.01%	2189
2016 Q1	$1.29M	Sell	43,800 -2,700	-6%	-$122K	﹤0.01%	2170
2015 Q4	$3.65M	Hold	46,500	–	–	0.01%	1518
2015 Q3	$3.5M	Hold	46,500	–	–	0.01%	1538
2015 Q2	$5.43M	Sell	46,500 -2,655	-5%	-$481K	0.01%	1317
2015 Q1	$11.1M	Hold	49,155	–	–	0.02%	877
2014 Q4	$11.1M	Buy	49,155 +241	+0.5%	+$53.5K	0.02%	877
2014 Q3	$11.7M	Buy	48,914 +2,414	+5%	+$496K	0.02%	869
2014 Q2	$3.07M	Sell	46,500 -2,715	-6%	-$193K	﹤0.01%	1830
2014 Q1	$3.98M	Buy	+49,215	New	+$5.78M	0.01%	1592
2013 Q4	–	Sell	-900	Closed	-$48K	–	4014
2013 Q3	$48K	Buy	+900	New	+$48.5K	﹤0.01%	3578

Other funds holding PBYI

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

California Public Employees Retirement System's PBYI Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Puma Biotechnology (PBYI) in Q2 2021, closing a stake of 62,300 shares — an estimated $606K sold.

California Public Employees Retirement System first reported a position in PBYI in Q3 2013 and held it in 30 quarters. The position peaked at $12.9M in Q3 2017. 120 funds tracked by Wall St. Rank hold PBYI as of Q2 2021.

California Public Employees Retirement System reported no remaining Puma Biotechnology position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 62,300 Puma Biotechnology shares in Q2 2021, an estimated $606K.
California Public Employees Retirement System first reported a position in Puma Biotechnology in Q3 2013 and held it in 30 quarters.
California Public Employees Retirement System's Puma Biotechnology position peaked at $12.9M in Q3 2017.
120 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.